Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

Thomas U. Marron; Matthew D. Galsky; Bachir Taouli; Maria Isabel Fiel; Stephen Ward; Edward Kim; David Yankelevitz; Deborah Doroshow; Emma Guttman-Yassky; Benjamin Ungar; Saurabh Mehandru; Benjamin J. Golas; Daniel Labow; John Sfakianos; Sujit S. Nair; Dimple Chakravarty; Michael Buckstein; Xiaoyu Song; Effi Kenigsberg; Sacha Gnjatic; Brian D. Brown; Joseph Sparano; Ashutosh Tewari; Myron Schwartz; Nina Bhardwaj; Miriam Merad

doi:10.1038/s41591-022-01948-3

Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

Brian D. Brown, Joseph Sparano, Ashutosh Tewari, Myron Schwartz, Nina Bhardwaj, Miriam Merad

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the version of this article initially published, the last name of author Emma Guttman-Yassky was incomplete and has now been amended in the HTML and PDF versions of the article.

Original language	English
Pages (from-to)	1723
Number of pages	1
Journal	Nature Medicine
Volume	28
Issue number	8
DOIs	https://doi.org/10.1038/s41591-022-01948-3
State	Published - Aug 2022

Access to Document

10.1038/s41591-022-01948-3

Cite this

Marron, T. U., Galsky, M. D., Taouli, B., Fiel, M. I., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman-Yassky, E., Ungar, B., Mehandru, S., Golas, B. J., Labow, D., Sfakianos, J., Nair, S. S., Chakravarty, D., Buckstein, M., Song, X., Kenigsberg, E., ... Merad, M. (2022). Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x). Nature Medicine, 28(8), 1723. https://doi.org/10.1038/s41591-022-01948-3

@article{181f50998ebe4b8e9f93ab54c3cbb47a,

title = "Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)",

abstract = "In the version of this article initially published, the last name of author Emma Guttman-Yassky was incomplete and has now been amended in the HTML and PDF versions of the article.",

author = "Marron, \{Thomas U.\} and Galsky, \{Matthew D.\} and Bachir Taouli and Fiel, \{Maria Isabel\} and Stephen Ward and Edward Kim and David Yankelevitz and Deborah Doroshow and Emma Guttman-Yassky and Benjamin Ungar and Saurabh Mehandru and Golas, \{Benjamin J.\} and Daniel Labow and John Sfakianos and Nair, \{Sujit S.\} and Dimple Chakravarty and Michael Buckstein and Xiaoyu Song and Effi Kenigsberg and Sacha Gnjatic and Brown, \{Brian D.\} and Joseph Sparano and Ashutosh Tewari and Myron Schwartz and Nina Bhardwaj and Miriam Merad",

note = "Publisher Copyright: {\textcopyright} 2022, Springer Nature America, Inc.",

year = "2022",

month = aug,

doi = "10.1038/s41591-022-01948-3",

language = "English",

volume = "28",

pages = "1723",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "8",

}

Marron, TU , Galsky, MD , Taouli, B , Fiel, MI , Ward, S , Kim, E, Yankelevitz, D, Doroshow, D , Guttman-Yassky, E , Ungar, B , Mehandru, S, Golas, BJ, Labow, D , Sfakianos, J, Nair, SS, Chakravarty, D, Buckstein, M, Song, X, Kenigsberg, E, Gnjatic, S , Brown, BD , Sparano, J , Tewari, A , Schwartz, M , Bhardwaj, N & Merad, M 2022, 'Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)', Nature Medicine, vol. 28, no. 8, pp. 1723. https://doi.org/10.1038/s41591-022-01948-3

TY - JOUR

T1 - Author Correction

T2 - Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

AU - Marron, Thomas U.

AU - Galsky, Matthew D.

AU - Taouli, Bachir

AU - Fiel, Maria Isabel

AU - Ward, Stephen

AU - Kim, Edward

AU - Yankelevitz, David

AU - Doroshow, Deborah

AU - Guttman-Yassky, Emma

AU - Ungar, Benjamin

AU - Mehandru, Saurabh

AU - Golas, Benjamin J.

AU - Labow, Daniel

AU - Sfakianos, John

AU - Nair, Sujit S.

AU - Chakravarty, Dimple

AU - Buckstein, Michael

AU - Song, Xiaoyu

AU - Kenigsberg, Effi

AU - Gnjatic, Sacha

AU - Brown, Brian D.

AU - Sparano, Joseph

AU - Tewari, Ashutosh

AU - Schwartz, Myron

AU - Bhardwaj, Nina

AU - Merad, Miriam

PY - 2022/8

Y1 - 2022/8

N2 - In the version of this article initially published, the last name of author Emma Guttman-Yassky was incomplete and has now been amended in the HTML and PDF versions of the article.

AB - In the version of this article initially published, the last name of author Emma Guttman-Yassky was incomplete and has now been amended in the HTML and PDF versions of the article.

UR - https://www.scopus.com/pages/publications/85134466255

U2 - 10.1038/s41591-022-01948-3

DO - 10.1038/s41591-022-01948-3

M3 - Comment/debate

AN - SCOPUS:85134466255

SN - 1078-8956

VL - 28

SP - 1723

JO - Nature Medicine

JF - Nature Medicine

IS - 8

ER -

Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

Abstract

Access to Document

Fingerprint

Cite this